168 related articles for article (PubMed ID: 29506494)
21. Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance.
Batta N; Pandey M
World J Surg Oncol; 2019 Nov; 17(1):198. PubMed ID: 31775759
[TBL] [Abstract][Full Text] [Related]
22. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
[TBL] [Abstract][Full Text] [Related]
23. Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer.
Kim HS; Lee H; Shin SJ; Beom SH; Jung M; Bae S; Lee EY; Park KH; Choi YY; Son T; Kim HI; Cheong JH; Hyung WJ; Park JC; Shin SK; Lee SK; Lee YC; Koom WS; Lim JS; Chung HC; Noh SH; Rha SY; Kim H; Paik S
Oncotarget; 2017 Jun; 8(24):38389-38398. PubMed ID: 28418920
[TBL] [Abstract][Full Text] [Related]
24. Genetic profiling of thymic carcinoma using targeted next-generation sequencing.
Shitara M; Okuda K; Suzuki A; Tatematsu T; Hikosaka Y; Moriyama S; Sasaki H; Fujii Y; Yano M
Lung Cancer; 2014 Nov; 86(2):174-9. PubMed ID: 25249426
[TBL] [Abstract][Full Text] [Related]
25. Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.
Liu X; Zhang M; Ying S; Zhang C; Lin R; Zheng J; Zhang G; Tian D; Guo Y; Du C; Chen Y; Chen S; Su X; Ji J; Deng W; Li X; Qiu S; Yan R; Xu Z; Wang Y; Guo Y; Cui J; Zhuang S; Yu H; Zheng Q; Marom M; Sheng S; Zhang G; Hu S; Li R; Su M
Gastroenterology; 2017 Jul; 153(1):166-177. PubMed ID: 28365443
[TBL] [Abstract][Full Text] [Related]
26. PIK3CA mutations in non-small cell lung cancer (NSCLC): genetic heterogeneity, prognostic impact and incidence of prior malignancies.
Scheffler M; Bos M; Gardizi M; König K; Michels S; Fassunke J; Heydt C; Künstlinger H; Ihle M; Ueckeroth F; Albus K; Serke M; Gerigk U; Schulte W; Töpelt K; Nogova L; Zander T; Engel-Riedel W; Stoelben E; Ko YD; Randerath W; Kaminsky B; Panse J; Becker C; Hellmich M; Merkelbach-Bruse S; Heukamp LC; Büttner R; Wolf J
Oncotarget; 2015 Jan; 6(2):1315-26. PubMed ID: 25473901
[TBL] [Abstract][Full Text] [Related]
27. Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.
Yilmaz AS; Ozer HG; Gillespie JL; Allain DC; Bernhardt MN; Furlan KC; Castro LT; Peters SB; Nagarajan P; Kang SY; Iwenofu OH; Olencki T; Teknos TN; Toland AE
Cancer; 2017 Apr; 123(7):1184-1193. PubMed ID: 27906449
[TBL] [Abstract][Full Text] [Related]
28. Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers.
Verri C; Borzi C; Holscher T; Dugo M; Devecchi A; Drake K; Sestini S; Suatoni P; Romeo E; Sozzi G; Pastorino U; Boeri M
J Thorac Oncol; 2017 Jun; 12(6):922-931. PubMed ID: 28302568
[TBL] [Abstract][Full Text] [Related]
29. Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases.
Allison DB; Lilo MT; Geddes S; Pallavajjalla A; Askin F; Gabrielson E; Zheng G; Li QK
Cancer Cytopathol; 2016 Jul; 124(7):485-92. PubMed ID: 27007084
[TBL] [Abstract][Full Text] [Related]
30. Genetic profiling as a clinical tool in advanced parathyroid carcinoma.
Kutahyalioglu M; Nguyen HT; Kwatampora L; Clarke C; Silva A; Ibrahim E; Waguespack SG; Cabanillas ME; Jimenez C; Hu MI; Sherman SI; Kopetz S; Broaddus R; Dadu R; Wanland K; Williams M; Zafereo M; Perrier N; Busaidy NL
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1977-1986. PubMed ID: 31309300
[TBL] [Abstract][Full Text] [Related]
31. Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing.
Roy-Chowdhuri S; de Melo Gagliato D; Routbort MJ; Patel KP; Singh RR; Broaddus R; Lazar AJ; Sahin A; Alvarez RH; Moulder S; Wheler JJ; Janku F; Gonzalez-Angulo AM; Chavez-MacGregor M; Valero V; Ueno NT; Mills G; Mendelsohn J; Yao H; Aldape K; Luthra R; Meric-Bernstam F
Am J Clin Pathol; 2015 Nov; 144(5):713-21. PubMed ID: 26486734
[TBL] [Abstract][Full Text] [Related]
32. Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
Ross JS; Gay LM; Wang K; Ali SM; Chumsri S; Elvin JA; Bose R; Vergilio JA; Suh J; Yelensky R; Lipson D; Chmielecki J; Waintraub S; Leyland-Jones B; Miller VA; Stephens PJ
Cancer; 2016 Sep; 122(17):2654-62. PubMed ID: 27284958
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
Ali SM; Pal SK; Wang K; Palma NA; Sanford E; Bailey M; He J; Elvin JA; Chmielecki J; Squillace R; Dow E; Morosini D; Buell J; Yelensky R; Lipson D; Frampton GM; Howley P; Ross JS; Stephens PJ; Miller VA
Oncologist; 2016 Jan; 21(1):33-9. PubMed ID: 26670666
[TBL] [Abstract][Full Text] [Related]
34. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
Au CH; Wa A; Ho DN; Chan TL; Ma ES
Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
[TBL] [Abstract][Full Text] [Related]
35. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
36. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.
Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS
Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923
[TBL] [Abstract][Full Text] [Related]
37. Genetic landscape of esophageal squamous cell carcinoma.
Gao YB; Chen ZL; Li JG; Hu XD; Shi XJ; Sun ZM; Zhang F; Zhao ZR; Li ZT; Liu ZY; Zhao YD; Sun J; Zhou CC; Yao R; Wang SY; Wang P; Sun N; Zhang BH; Dong JS; Yu Y; Luo M; Feng XL; Shi SS; Zhou F; Tan FW; Qiu B; Li N; Shao K; Zhang LJ; Zhang LJ; Xue Q; Gao SG; He J
Nat Genet; 2014 Oct; 46(10):1097-102. PubMed ID: 25151357
[TBL] [Abstract][Full Text] [Related]
38. Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer.
Park YH; Shin HT; Jung HH; Choi YL; Ahn T; Park K; Lee A; Do IG; Kim JY; Ahn JS; Park WY; Im YH
Oncotarget; 2015 Oct; 6(31):32027-38. PubMed ID: 26397225
[TBL] [Abstract][Full Text] [Related]
39. Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report.
Valtcheva N; Lang FM; Noske A; Samartzis EP; Schmidt AM; Bellini E; Fink D; Moch H; Rechsteiner M; Dedes KJ; Wild PJ
BMC Cancer; 2017 Jan; 17(1):66. PubMed ID: 28103826
[TBL] [Abstract][Full Text] [Related]
40. Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria.
Driver BR; Portier BP; Mody DR; Deavers M; Bernicker EH; Kim MP; Teh BS; Santacruz JF; Kopas L; Munden RF; Cagle PT
Arch Pathol Lab Med; 2016 Apr; 140(4):312-7. PubMed ID: 26430808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
